A detailed history of North Star Asset Management Inc transactions in Repligen Corp stock. As of the latest transaction made, North Star Asset Management Inc holds 92,130 shares of RGEN stock, worth $13.5 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
92,130
Previous 93,724 1.7%
Holding current value
$13.5 Million
Previous $11.8 Million 16.05%
% of portfolio
0.64%
Previous 0.58%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.79 - $167.35 $190,945 - $266,755
-1,594 Reduced 1.7%
92,130 $13.7 Million
Q2 2024

Aug 05, 2024

BUY
$120.0 - $182.95 $182,160 - $277,718
1,518 Added 1.65%
93,724 $11.8 Million
Q1 2024

May 08, 2024

BUY
$170.78 - $208.42 $93,929 - $114,631
550 Added 0.6%
92,206 $17 Million
Q4 2023

Feb 01, 2024

SELL
$114.17 - $185.35 $4,680 - $7,599
-41 Reduced 0.04%
91,656 $16.5 Million
Q3 2023

Oct 26, 2023

BUY
$138.78 - $176.51 $52,042 - $66,191
375 Added 0.41%
91,697 $14.6 Million
Q2 2023

Aug 09, 2023

BUY
$138.42 - $180.31 $321,964 - $419,401
2,326 Added 2.61%
91,322 $12.9 Million
Q1 2023

May 10, 2023

BUY
$154.26 - $198.1 $295,562 - $379,559
1,916 Added 2.2%
88,996 $15 Million
Q4 2022

Mar 06, 2023

BUY
$162.42 - $220.56 $413,196 - $561,104
2,544 Added 3.01%
87,080 $14.7 Million
Q3 2022

Nov 08, 2022

BUY
$160.42 - $256.21 $226,673 - $362,024
1,413 Added 1.7%
84,536 $15.8 Million
Q2 2022

Jul 28, 2022

BUY
$140.68 - $188.02 $61,195 - $81,788
435 Added 0.53%
83,123 $13.5 Million
Q1 2022

Apr 29, 2022

BUY
$161.19 - $257.96 $184,562 - $295,364
1,145 Added 1.4%
82,688 $15.6 Million
Q4 2021

Feb 07, 2022

SELL
$247.59 - $304.47 $494,684 - $608,331
-1,998 Reduced 2.39%
81,543 $21.6 Million
Q3 2021

Oct 20, 2021

SELL
$194.77 - $324.21 $1.18 Million - $1.97 Million
-6,082 Reduced 6.79%
83,541 $24.1 Million
Q2 2021

Jul 30, 2021

SELL
$165.87 - $220.95 $139,662 - $186,039
-842 Reduced 0.93%
89,623 $17.9 Million
Q1 2021

Apr 29, 2021

SELL
$180.37 - $226.26 $1.02 Million - $1.28 Million
-5,640 Reduced 5.87%
90,465 $17.6 Million
Q4 2020

Feb 16, 2021

SELL
$148.08 - $206.57 $389,154 - $542,865
-2,628 Reduced 2.66%
96,105 $18.4 Million
Q3 2020

Nov 02, 2020

SELL
$122.51 - $158.27 $1.01 Million - $1.31 Million
-8,272 Reduced 7.73%
98,733 $14.6 Million
Q2 2020

Jul 28, 2020

SELL
$94.33 - $140.48 $1.65 Million - $2.46 Million
-17,494 Reduced 14.05%
107,005 $13.2 Million
Q1 2020

Apr 24, 2020

SELL
$84.96 - $109.14 $498,715 - $640,651
-5,870 Reduced 4.5%
124,499 $12 Million
Q4 2019

Feb 06, 2020

SELL
$73.84 - $93.08 $275,866 - $347,746
-3,736 Reduced 2.79%
130,369 $12.1 Million
Q3 2019

Oct 25, 2019

SELL
$76.65 - $95.51 $754,925 - $940,677
-9,849 Reduced 6.84%
134,105 $10.3 Million
Q2 2019

Aug 12, 2019

SELL
$54.2 - $85.95 $191,326 - $303,403
-3,530 Reduced 2.39%
143,954 $12.4 Million
Q1 2019

Apr 26, 2019

BUY
$49.45 - $62.8 $105,823 - $134,392
2,140 Added 1.47%
147,484 $8.71 Million
Q4 2018

Jan 29, 2019

SELL
$48.26 - $68.88 $233,916 - $333,861
-4,847 Reduced 3.23%
145,344 $7.67 Million
Q3 2018

Oct 29, 2018

SELL
$46.8 - $58.97 $973,159 - $1.23 Million
-20,794 Reduced 12.16%
150,191 $8.33 Million
Q2 2018

Aug 10, 2018

SELL
$35.26 - $47.04 $10,225 - $13,641
-290 Reduced 0.17%
170,985 $8.04 Million
Q1 2018

Apr 27, 2018

BUY
$30.92 - $37.27 $1.91 Million - $2.3 Million
61,630 Added 56.21%
171,275 $6.2 Million
Q4 2017

Feb 01, 2018

BUY
$32.53 - $38.92 $2.75 Million - $3.29 Million
84,486 Added 335.81%
109,645 $3.98 Million
Q3 2017

Oct 25, 2017

BUY
$36.98 - $46.06 $356,856 - $444,479
9,650 Added 62.22%
25,159 $964,000
Q3 2017

Oct 25, 2017

SELL
$36.98 - $46.06 $186,379 - $232,142
-5,040 Reduced 24.53%
15,509 $546,000
Q2 2017

Aug 16, 2017

BUY
N/A
20,549
20,549 $852,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track North Star Asset Management Inc Portfolio

Follow North Star Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on North Star Asset Management Inc with notifications on news.